All News Spineway

Equities

Market Closed - Euronext Paris Other stock markets 16:26:05 02/05/2024 BST			5-day change	1st Jan Change
0.7499 ^EUR	+0.66%		-21.93%	-88.97%

04-17	Spineway: punished despite a solid first quarter	CF
04-16	Spineway SA Announces Revenue Results for the First Quarter of 2024	CI

Spineway: punished despite a solid first quarter	04-17	CF
Growth of 28% of 2024 first quarter revenue	04-16	AQ
Spineway SA Announces Revenue Results for the First Quarter of 2024	04-16	CI
2023 Shareholders General Meeting	03-26	AQ
Reverse stock split	02-29	AQ
Preparatory documents for the General Meeting as of of March 25, 2024	02-19	AQ
SPINEWAY : 2023 annual results	02-07	AQ
Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2023	02-07	CI
Spineway: strong sales growth in 2023	01-26	CF
Increase of 2023 revenue at €10.5 million	01-25	AQ
Shares reverse split	01-05	AQ
SPINEWAY : International rollout of the VEOS implant range - First implants in Spain - New approvals in Colombia and Indonesia	11-24	AQ
Extraordinary General Meeting's minute	11-13	AQ
Spineway Names Deputy CEO	11-08	MT
Deputy Chief Executive Officer's appointment	11-07	AQ
Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer	11-07	CI
US 2023 NASS conference : VEOS System	11-02	AQ
Spineway : Document AMF CP. 2023E935253	27/10/23	PU
Spineway : Document AMF CP. 2023E934680	25/10/23	PU
Spineway : Document AMF CP. 2023E934420	24/10/23	PU

No results for this search